HCAT — Health Catalyst Balance Sheet
0.000.00%
- $86.10m
- $143.61m
- $311.14m
Annual balance sheet for Health Catalyst, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 445 | 363 | 318 | 392 | 95.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 48.8 | 48 | 60.3 | 57.2 | 59.1 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 508 | 428 | 393 | 466 | 169 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 44.4 | 42.6 | 39.6 | 41.5 | 40.5 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 832 | 752 | 702 | 859 | 503 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 93.1 | 82.5 | 89 | 326 | 89.6 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 310 | 327 | 335 | 494 | 257 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 522 | 425 | 367 | 365 | 246 |
| Total Liabilities & Shareholders' Equity | 832 | 752 | 702 | 859 | 503 |
| Total Common Shares Outstanding |